Authors/Disclosures
|
Robert P. Rubens, MD, MBA, FAAN, FAAN
(NeuroDevMA Consulting, Inc.)
|
Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals. |
|
Joshua Lukas, MD
(Riverside Methodist Hospital (Ohio Health))
|
Dr. Lukas has nothing to disclose. |
|
Thomas C. Wessel, MD
|
No disclosure on file |
|
Catherine Legault, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Ilana Spokoyny, MD
(Sutter West Bay Medical Group)
|
Dr. Spokoyny has nothing to disclose. |
|
|
No disclosure on file |
|
Andrew D. Campbell, PhD
|
No disclosure on file |
|
Vivien H. Lee, MD, FAAN
(OSU Comprehensive Neurovascular Center)
|
Dr. Lee has nothing to disclose. |
|
Kathleen Bowler, PhD
|
No disclosure on file |
|
Thomas Roth, PhD
(Henry Ford Hospital)
|
Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. |
|
Sevim Erdem-Ozdamar, MD
|
No disclosure on file |